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Several growth factors are effective for salvaging myocardium and limiting infarct size in
experimental studies with small animals. Their beneﬁt in large animals and feasibility in
clinical practice remains to be elucidated. We investigated the cardioprotective effect of
midkine (MK) in swine subjected to ischemia/reperfusion (I/R). I/R was created by left ante-
rior descending coronary artery occlusion for 45min using a percutaneous over-the-wire
balloon catheter. MK protein was injected as a bolus through the catheter at the initi-
ation of reperfusion [MK-treated (MKT) group]. Saline was injected in controls (CONT).
Infarct size/area at risk (24h after I/R) in MKT was almost ﬁve times smaller than in
CONT. Echocardiography in MKT revealed a signiﬁcantly higher percent wall thickening
of the interventricular septum, a higher left ventricular (LV) fractional shortening, and a
lower E/e  (ratio of transmitral to annular ﬂow) compared with CONT. LV catheteriza-
tion in MKT showed a lower LV end-diastolic pressure, and a higher dP/dtmax compared
with CONT.Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end-labeling-
positive myocytes and CD45-positive cell inﬁltration in the peri-infarct area were signif-
icantly less in MKT than in CONT. Here, we demonstrate that a single intracoronary
injection of MK protein in swine hearts at the onset of reperfusion dramatically reduces
infarct size and ameliorates systolic/diastolic LV function.This beneﬁcial effect is associated
with a reduction of apoptotic and inﬂammatory reactions. MK application during percuta-
neous coronary intervention may become a promising adjunctive therapy in acute coronary
syndromes.
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INTRODUCTION
Current treatment of acute myocardial infarction is focused on
limiting the duration of the ischemic period by disrupting the
occlusioninthecoronaryarteriesandreestablishmentofcoronary
ﬂow. However, post ischemic reperfusion may induce myocardial
dysfunction due to microcirculatory ﬂow disturbances, aggrava-
tion of oxidative stress,calcium overload,excessive inﬂammation,
andactivationofapoptosis(Moensetal.,2005).Despitenumerous
strategies aiming to prevent ischemia/reperfusion (I/R) induced
myocardial damage,no effective agent is available in clinical prac-
tice. Several growth factors have been shown to protect against
I/R injury in small animals like rodents, but their way into clin-
ical practice is still far away by insufﬁcient effects or unaccept-
able side effects in large animals or humans. Recently, we have
reported that midkine (MK) has a protective role against reper-
fusion injury, and that it can diminish myocardial infarct size in
both acute and chronic ischemic mouse models (Horiba et al.,
2006; Takenaka et al., 2009). However, its cardioprotective effect
in swine is unknown.
Midkineisaheparin-bindinggrowthfactorwith45%sequence
homologywithpleiotrophin(alsocalledheparin-bindinggrowth-
associated molecule, HB-GAM). It is structurally unrelated to
other heparin-binding growth factors such as ﬁbroblast growth
factors.MKgeneexpressionishighinmalignanttumorsinvarious
tissues and is expected to become a new tumor marker (Mura-
matsu, 2002). MK is involved in various anabolic activities, such
as neural growth (Michikawa et al., 1993), migration of inﬂam-
matory leukocytes, and preservation and repair of injured tissues
(Horiba et al., 2006). MK has anti-apoptotic activity in embry-
onic neural cells (Yokota et al.,1998; Kadomatsu and Muramatsu,
2004)andinretinalphotoreceptorcells(Unokietal.,1994).Inthe
murine heart, we have shown that this effect occurs not only in
acuteischemiabutalsoinchronicmyocardialinfarction(Takenaka
et al., 2009). This study aims to elucidate whether MK may be
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attractive for clinical use. We assessed the acute effect of MK in
swine hearts subjected to I/R.
MATERIALS AND METHODS
ISCHEMIA AND REPERFUSION
All animal experiments were performed in accordance with the
regulations adopted by the National Institute of Health and
approved by the Animal Care and Use Committee of Nagoya
University. In male castrated swine weighing 37–42kg, anesthesia
was induced by ketamine (10mg/kg, i.m.) and thiamylal sodium
(0.3mg/kg, i.v.), and maintained by inhalation of sevoﬂurane
(1%).Oxygensaturation,aorticbloodpressure,centralbodytem-
perature, and a three-lead (I, II, III) electrocardiogram (ECG)
were monitored continuously throughout the procedure. An
over-the-wire balloon was placed in the left anterior descending
(LAD) coronary artery distal to the bifurcation of the ﬁrst diag-
onal branch and inﬂated. Total coronary occlusion and patency
of the ﬁrst diagonal branch was conﬁrmed by injection of con-
trast agent under ﬂuoroscopy and was further conﬁrmed by ST
segment elevation on the ECG. Because the swine is susceptible to
ischemia-induced ventricular ﬁbrillation (VF), we intravenously
infused 100mg of lidocaine 5min before balloon inﬂation. Five
minutes before the end of the 45-min period of ischemia, the
guidewirewasremovedandhumanderivedMK5μg/kgdissolved
in 10ml saline [MK-treated (MKT) group, n =9] or 10ml saline
alone [control (CONT) group, n =12] were injected at 1ml/min
through the guide-wire lumen of the balloon catheter. The total
infusion time was 10min and the infusion lasted during the ﬁrst
5min of reperfusion. The dose of MK protein employed in the
present study (5μg/kg) was comparable to that used in our pre-
vious experiments in a mouse model of I/R (Horiba et al., 2006),
where direct injection of 20μl human recombinant MK protein
(10μg/ml) into the left ventricular (LV) free wall – corresponding
to 8–9μg/kg of body weight – was shown to reduce infarct size
signiﬁcantly 24h after I/R. Human recombinant MK protein was
generated and puriﬁed as described previously (Horiba et al.,
2000).
INFARCT SIZE DETERMINATION
Twenty-four hours after reperfusion, swine were anesthetized
again as above. After assessment of left ventriculographical (LVG)
andechocardiographicalparameters,KClwasinjectedthroughan
8-Fr catheter inserted in the ascending aorta to arrest the heart
in diastole. The heart was rapidly harvested and the LAD was
occluded surgically at the site where the balloon distal marker
was positioned. The hearts from three CONT and three MKT
swine were then perfused with 20ml of 1% Evans blue from
the ascending aorta, and each was dissected into four slices. The
slices were further stained with 1% 2,3,5-triphenyltetrazolium
chloride (TTC) to demarcate the unperfused area (area at risk,
AAR) and the TTC-positive viable tissue. The stained slices were
photographed to evaluate the AAR and infarct size as described
previously (Horiba et al.,2006).
Serum troponin T levels were measured as an indicator of car-
diaccytolysisinsevenCONTandsevenMKTswinebeforeballoon
inﬂation (“PRE”) and at 2 and 24h of reperfusion.
MEASUREMENT OF SYSTOLIC AND DIASTOLIC FUNCTION
Left ventricular catheterization, LVG, and echocardiography were
performed to evaluate LV systolic and diastolic function before
balloon inﬂation (“PRE”) and at 30min (“POST”) and 24h of
reperfusion. Ejection fraction (EF) and hypokinetic areas were
measured by LVG (60˚ right anterior oblique projection). To esti-
mate the LV local hypokinetic area, the percentage of abnormal
contracting segments (%ACS) was measured as the percent ratio
of hypokinetic chords among the total chords in the centerline
method of regional wall motion analysis (Sweet et al., 1975).
The number of hypokinetic chords was automatically counted
with computer software (QCA-CMS, Goodman, Japan). LV end-
diastolic pressure (LVEDP),the maximum ﬁrst derivative of pres-
sure over time (dP/dtmax) and the minimum ﬁrst derivative of
pressureovertime(dP/dtmin)werecalculatedfromtheLVtracings
by computer software (OP-310G, Nihon Kohden, Japan).
In transthoracic echocardiography (SONOS 5500, Philips), LV
fractional shortening (%FS),and the percentage thickening of the
interventricularseptum(%IVS)andtheLVposteriorwall(%PW)
were measured as indices of LV systolic function, and the ratio of
transmitral and annular ﬂow (E/e ) was measured as an index of
LV diastolic function (Nagueh et al., 1998; Kasner et al., 2007).
DETECTION OF APOPTOSIS AND INFLAMMATION
In ﬁve CONT and ﬁve MKT hearts excised at 24h after reper-
fusion, apoptotic myocardial cells were identiﬁed by terminal
deoxynucleotidyl transferase (TdT)-mediated dUTP nick end-
labeling (TUNEL) staining with the use of an in situ apoptosis
detection kit (Apoptag, Millipore). In those hearts, immunos-
taining of inﬂammatory cells was also performed by labeling the
LV tissue sections with anti-mouse CD45 (leukocyte common
antigen) antibody (LaboratoryVision Corporation,Fremont,CA,
USA).Exposuretosecondaryantibodyconjugatedwithgoatanti-
rat IgG (Jackson Laboratory) was followed by incubation with
biotinyl-tyramide and streptavidin–horseradish peroxidase.
ORGAN DEPOSITION OF EXOGENOUS MK
In3swine(inadditiontothe21fortheI/Rexperiments),MKpro-
tein labeled with rhodamine was injected into the LAD through
the over-the-wire balloon catheter at the initiation of reperfu-
sion (total infusion time was 10min from 5min before the end
of 45-min ischemia period). The labeling was performed using
EZ-Label™ rhodamine Protein Labeling Kit (PIERCE Biotech-
nology). Brieﬂy, after pre-dialysis with borate buffer (pH 8.5),
100μg MK was mixed with 8μl rhodamine solution and then
incubated for 1h at room temperature. Rhodamine-labeled MK
solution was then dialyzed with phosphate-buffered saline (PBS)
to remove excess ﬂuorescent dye. The hearts were excised 24h
after I/R,and the LV tissue sections were prepared to visualize the
tissue distribution of rhodamine-labeled MK protein under laser
microscopy.
STATISTICAL ANALYSIS
Datawereexpressedasmean±SEM.Statisticalcomparisonswere
eitherperformedbyANOVA,orthepairedStudent’st-test,orFis-
cher’s exact test when appropriate. Details are described in the
legends to the Figures. Differences were considered signiﬁcant
when p<0.05.
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RESULTS
PROTOCOL AND MORTALITY RATE
Figure 1A shows the protocol of I/R insult in swine hearts by bal-
loon inﬂation for 45min,and Figure1B shows an angiographical
view of the balloon location. There was not a single episode of
VF during the ischemic period, but it should be emphasized that
this was in the prophylactic presence of lidocaine. VF occurred in
11/12 CONT and 8/9 MKT swine during 2h of reperfusion. All
episodes of VF were successfully deﬁbrillated by transthoracic DC
shocks. Figure 1C shows the mortality rate. Although all swine
survived at 2h of reperfusion,4/12 (33.3%) of CONT died within
24h after reperfusion, whereas 1/9 (11.1%) of MKT died during
the same period (p=0.34, Fischer’s exact).
REDUCTION OF INFARCT SIZE
Figure 2A shows the appearance of the ventricular area distal
from the site of coronary occlusion just before extirpation of the
hearts. As seen at the surface, a uniform mass of whitish tissue
was seen at the coronary occlusion area including the LAD area
in the CONT (Figure 2A, left), whereas smaller mottled whitish
lesions were seen in the same area of MKT (Figure 2A, right). To
assess infarct dimensions, we stained the hearts with Evans blue
and TTC. Figure 2B shows representative examples of TTC and
Evans blue double staining in infarcted hearts. TTC stains surviv-
ing tissue red, leaving infarcted areas white. Although the areas at
riskforocclusionweresimilarbetweenthetwogroups(Figure2C,
top panel),MK treatment reduced infarct size by 79% (Figure2C,
bottom panel).
FIGURE 1 | Ischemia/reperfusion (I/R) experiments. (A) Protocol of I/R
insult.The left anterior descending (LAD) coronary artery distal to the
bifurcation to the ﬁrst diagonal branch was occluded by inﬂation of an
over-the-wire balloon to create myocardial ischemia for 45min followed by
reperfusion for 24h. Midkine protein (MK 5μg/kg) or saline (CONT) was
injected into the coronary artery for 10min through the guide-wire lumen,
beginning 5min before the end of ischemia period. (B) Position of the
occlusion balloon. An X-ray image was taken during LAD angiography.Two
arrows indicate proximal and distal ends of the balloon positioned at the
site of occlusion. (C)The mortality rate of animals during the 24-h
reperfusion. Four of 12 (33.3%) CONT, whereas 1/9 (11.1%) MK-treated
swines died (p =0.34, Fischer’s exact test).
SerumtroponinT,amarkerof myocardialcelldamage,wasele-
vated at 2 and 24h after I/R insult. The elevation at 24h in MKT
was signiﬁcantly less than in CONT (Figure 2D).
PRESERVATION OF SYSTOLIC AND DIASTOLIC LV FUNCTION
We investigated LV systolic and diastolic function by echocardio-
graphy (Figure 3). At baseline (“PRE”) and at 30min of reper-
fusion (“POST”), there were no signiﬁcant differences between
the CONT and MKT in any assessed parameter. However, at 24h
of reperfusion (“24h”), lower E/e , higher percentages of frac-
tional shortening (%FS), and higher %IVS were observed in the
MKT compared with the CONT. Thus, MKT swine showed par-
tial recovery of E/e  and %IVS, whereas CONT swine showed no
recovery in these parameters. Percentage thickening of posterior
wall (%PW) was unaffected by the I/R insult both in CONT and
MKT swine (data not shown).
Figure 4 shows the results obtained in LVG and LV catheteri-
zation. In both CONT and MKT swine, EF decreased and %ACS
increased signiﬁcantly at 30min of reperfusion (“POST”).At 24h
reperfusion, CONT swine showed a further decrease in EF and
a further increase of %ACS, whereas MKT swine did not show
such a deterioration (Figure4B). In the CONT group LVEDP was
signiﬁcantly higher at 24h reperfusion compared with baseline
(Figure 4C). This was not the case in the MKT group, although
therehadbeenasigniﬁcantdifferencebetween“POST”and“PRE”
in the MKT group, but not the CONT group (Figure 4C). Also,
at 24h reperfusion LVEDP was signiﬁcantly lower in the MKT
group compared with the CONT group (ANOVA). The dP/dtmax
was signiﬁcantly lower at “POST” compared with “PRE” in both
groups (Figure4C). However,at 24h reperfusion this still was the
case (compared with “PRE”) in the CONT group, but no longer
in the MKT group. At 24h of reperfusion dP/dtmax was signiﬁ-
cantly higher in the MKT group compared with the CONT group
(Figure 4C, ANOVA). In the CONT and the MKT groups, the
dP/dtmin at“POST”decreased similarly from baseline (“POST”),
and the change was reversed at 24h of reperfusion (data not
shown).
Figure5summarizessystolicanddiastolicbloodpressure(sBP,
dBP) at baseline (“PRE”), and at 30min (“POST”), and 24h of
reperfusion. There were no signiﬁcant difference in these para-
meters between CONT and MKT swine at any moment. In both
CONT and MKT swine,sBP and dBP at“POST”decreased signif-
icantly from“PRE.”At 24h of reperfusion, sBP and dBP in MKT
increased signiﬁcantly compared with “POST.” However, both in
the CONT and the MKT groups the sBP and dBP values were
not signiﬁcantly different at 24h of reperfusion and at baseline
(“PRE”). We emphasize that each animal in fact served as its own
control.
Table 1 summarizes ECG parameters measured at baseline
(“PRE”), 30min (“POST”), and 24h of reperfusion. In both
CONT and MKT swine, I/R caused no signiﬁcant changes in PQ
interval, QRS duration, and QT interval. RR interval at 24h was
decreased similarly in CONT and MKT. There were no signiﬁcant
differences in these parameters between CONT and MKT at any
moment of the ECG recording. The ratio of heart weight/body
weight measured after 24h of reperfusion was comparable in
CONT and MKT.
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FIGURE 2 | Infarct size and serum troponinT of swine subjected to I/R
insult. (A) External view of the hearts prior to extirpation (24h after I/R insult).
Macroscopic infarct area (whitish lesion) downstream the coronary occlusion
in the MK-treated (MKT) heart was much smaller than that in CONT heart. (B)
Representative pictures of ventricular tissue sections from CONT and MKT
swine at 24h after I/R insult.Tissue stained blue by Evans blue represents
non-ischemic area; tissue stained red byTTC indicates viable area.Tissue not
stained by either Evans blue orTTC appears pale to white and represents
infarct myocardium. (C) Infarct size was measured as the percentage of LV
area of that of total ischemic area at risk (AAR). Values are mean±SEM of
AAR/LV and infarct size/AAR (CONT n=3, MKT n=3; *p<0.05 vs. CONT,
ANOVA). (D) Serum troponinT levels before (“PRE”), 2 and 24h after I/R
insult. Values are mean±SEM (CONT, n=7; MKT, n=7).The differences
between “PRE,” “POST,” and “24h” within the CONT and MKT groups were
tested by the paired Student’s t-test in such a way that each animal served as
its own control (
#p <0.05 vs. PRE,
†p <0.05 vs. POST).The difference
between the CONT and MKT groups at any moment was tested by ANOVA
(*p <0.05 vs. CONT).
APOPTOTIC RESPONSE AND INFILTRATION OF INFLAMMATORY CELLS
Apoptotic and inﬂammatory responses of swine hearts were
assessed 24h after I/R insult by TUNEL staining and immunola-
belingof CD45intheperi-infarctareaof LVtissue.MKtreatment
signiﬁcantly decreased the number of TUNEL-positive cells com-
pared with CONT (Figure 6A). MK treatment also caused a
signiﬁcantreductionofCD45-positivecellscomparedwithCONT
(Figure 6B).
EXOGENOUS MK DEPOSITION IN THE INFARCT AREA
In three swine, we injected rhodamine-labeled MK protein into
the LAD at the onset of reperfusion in order to evaluate the local
distribution of exogenous MK. Representative results are shown
in Figure 6C. The deposition of MK-rhodamine was clearly rec-
ognized in the peri-infarct area; it was absent in the normal and
infarct areas. Similar results were obtained in two other swine
hearts. This observation is consistent with our previous report on
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FIGURE3|E c hocardiographic assessment of LV function before and
after I/R insult. (A) Representative M-mode LV images of a CONT and a MKT
swine 24h after I/R. (B) Parameters representing diastolic and systolic LV
function. Values are mean±SEM of the ratio of transmitral to annular ﬂow
(E/e
 ), percentage LV fractional shortening (%FS), and percentage thickening
of interventricular septum (%IVS) measured before (“PRE”), 30min after
(“POST”), and 24h after I/R (CONT, n=8; MKT, n=8).The differences
between “PRE,” “POST,” and “24h” within the CONT and MKT groups were
tested by the paired Student’s t-test in such a way that each animal served as
its own control (
#p <0.05 vs. PRE,
†p <0.05 vs. POST).The difference
between the CONT and MKT groups at any moment was tested by ANOVA
(*p<0.05 vs. CONT).
the localization of endogenous MK protein in mice subjected to
I/R (Horiba et al.,2006).
DISCUSSION
The present study demonstrates that MK plays a crucial role
in cardioprotection in response to I/R. We used a swine model
of 45min myocardial ischemia by LAD occlusion with subse-
quent reperfusion to investigate the effect of acute MK admin-
istration on infarct size and myocardial dysfunction. Our study
indicates that favorable effects can be produced with a sin-
gle, intracoronary administration of MK, delivered just before
a 24-h period of reperfusion. In our experimental setting, no
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FIGURE 4 | Left ventricular function assessed by catheterization and
LVG before and after I/R. (A) Representative images of LVG (60˚ right
anterior oblique projection) at 24h after I/R. Normal kinetic and hypokinetic
chords (blue and red bars, respectively) were drawn along the centerline
methods, and percentage abnormality segments (%ACS) was counted
automatically using a computer software (QCA-CMS, Goodman, Japan).
Hypokinetic area (a zone of red bars) in the MKT swine is appreciably less
than that in the CONT swine. (B) Ejection fraction (EF) and %ACS measured
in LVG before (“PRE”), 30min after I/R (“POST”), and 24h after I/R. Values
are mean±SEM (CONT, n=7; MKT, n=8). (C) LV end-diastolic pressure
(LVEDP) and maximum ﬁrst derivative of LV pressure (dP/dtmax) measured
before (PRE), 30min after I/R (“POST”), and 24h after I/R. Values are
mean±SEM (CONT, n=8; MKT, n=8).The differences between “PRE,”
“POST,” and “24h” within the CONT and MKT groups were tested by the
paired Student’s t-test in such a way that each animal served as its own
control (
#p <0.05 vs. PRE,
†p <0.05 vs. POST).The difference between the
CONT and MKT groups at any moment was tested by ANOVA (*p<0.05
vs. CONT).
signiﬁcant hemodynamic perturbation was noted by such MK
treatment.
INFARCT SIZE REDUCTION AND FUNCTIONAL ASPECTS
Current evidence suggests that prevention of infarct expansion
during the vulnerable very early period after coronary occlusion
may abort the whole process of remodeling (Kelley et al., 1999).
At present, the therapeutic strategy consists of acute unloading
of the left ventricle, within the ﬁrst 24h of myocardial damage
(Jugdutt, 1993; Sutton and Sharpe, 2000). Many successful strate-
gies have been developed in animal studies to reduce reperfusion
damage and reperfusion-induced apoptosis. However, most of
theseapproacheshavelimitedrelevanceinaclinicalsettingandthe
resultsinclinicaltrialshavebeendisappointing(Baranetal.,2001;
Simons et al., 2002; Henry et al., 2003). Using this swine model
of I/R,we have demonstrated that a single intracoronary injection
of MK protein at the onset of reperfusion leads to a reduction in
infarctsize,amorenormalventriculargeometryandfunctionand
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FIGURE 5 | Blood pressure (BP) response to I/R. Systolic BP (sBP) and
diastolic BP (dBP) were measured before (“PRE”), 30min after I/R (“POST”),
and 24h after I/R. Values are mean±SEM (CONT, n=8; MKT, n=8).The
differences between “PRE,” “POST,” and “24h” within the CONT and MKT
groups were tested by the paired Student’s t-test in such a way that each
animal served as its own control (
#p <0.05 vs. PRE,
†p <0.05 vs. POST).The
difference between the CONT and MKT groups at any moment was tested by
ANOVA.
Table 1 | Electrocardiogram parameters of control and MK-treated swine.
Condition Group HW/BW RR (ms) PQ (ms) QRS (ms) QT (ms) QTc (ms)
PRE CONT n.a. 617±41 97±33 7 ±1 325±25 412±19
MKT n.a. 649±28 97±23 9 ±1 337±17 417±12
POST CONT n.a. 653±30 102±34 0 ±2 338±17 417±11
MKT n.a. 580±31 98±43 8 ±2 303±15 398±9
24h CONT 0.45±0.02 542±27# 96±23 9 ±1 278±13 378±8
MKT 0.43±0.01 560±20# 98±24 0 ±1 293±10 391±7
Values are mean±SEM. ECG data were obtained before I/R (PRE), 30min of reperfusion (POST), and 24h of reperfusion (24h). CONT, control swine (n=8); MKT,
midkine-treated swine (n=8); QTc=QT/(RR/1000)
1/2. Body weight (BW) measured at PRE was 40±1kg for CONT, and 39±1kg for MKT (ns). Heart weight (HW)
measured at 24h was 178±3g for CONT, and 167±3g for MKT (ns).The differences between “CONT,” “POST,” and “24h” within the CONT and MKT groups were
tested by the paired Student’s t-test in such a way that each animal served as its own control (#p<0.05 vs. PRE).The difference between the CONT and MKT groups
at any moment was tested by ANOVA.
ananti-apoptoticreaction.Mortalityrateof MKTswinetendedto
be less than that of CONT swine, but the difference did not reach
statistical signiﬁcance. The lack of signiﬁcance could be due to
the small experimental group size and the short follow-up period
(24h).
A localized intracoronary delivery strategy rather than global
myocardial infusion is appealing from the point of safety. This
relates to the ease of administration, the avoidance of open chest
surgery, and ﬁrst of all, an only 10min delay to recanalization
as adjunctive therapy with percutaneous coronary intervention
(PCI).Inthisstudy,MKwasadministeredthroughtheguide-wire
lumen of the balloon catheter, starting 5min before reperfusion.
This mimics the clinical situation of a patient with 100% occlu-
sionsubjectedtoPCIasanadjunctivetherapyinthesamesurgical
session. An over-the-wire balloon was used because it permits
injection of MK through the guide-wire lumen of the catheter.
As a result, MK can be administered selectively into the ischemic
lesion without a wash-out effect by coronary ﬂow.
MECHANISTIC ASPECTS
In a previous report,we compared the apoptotic response in asso-
ciation with ischemic myocardial injury in MK knock-out mice
(Mdk−/−) and wild type mice subjected to I/R (Horiba et al.,
2006).Theinfarctsizeandapoptosisintheperi-infarctarea,which
was quantiﬁed by TUNEL staining, were signiﬁcantly worse in
Mdk−/− mice than in wild type mice. In mouse cultured car-
diomyocytes subjected to hypoxia/reoxygenation, application of
exogenous MK prevented apoptosis through upregulation of Bcl-
2andphosphorylationofERK-1/2(Horibaetal.,2006).Inanother
study we assessed the long-term effects of MK treatment in a
mouse model of myocardial infarction.We demonstrated that the
ratio of Bax to Bcl-2 and the expression of p-Bad (p-bcl-xl-bcl-
associated death promoter) in LV myocardium 28days after the
creation of infarction were signiﬁcantly decreased and increased,
respectively in the mice treated with exogenous MK (Takenaka
et al., 2009). These observations suggest that MK plays a protec-
tive role against myocardial injury by prevention of apoptosis. In
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FIGURE 6 |Apoptotic and inﬂammatory reaction to I/R, and myocardial
deposition of exogenous MK protein. (A)TUNEL staining and quantiﬁcation
of apoptosis in the LV peri-infarct area of CONT and MKT swine. Left,
representativeTUNEL -stained sections from a CONT and a MKT swine at 24h
after I/R. Right, apoptotic cell populations were estimated byTUNEL -positive
nuclei/total nuclei (%). Values are mean±SEM (CONT, n=5; MKT, n=5; ﬁve
ﬁelds of each specimen; *p<0.05 vs. CONT, ANOVA). (B) CD45 staining and
quantiﬁcation of inﬂammatory cell inﬁltration. Left, representative
CD45-stained LV sections from a CONT and a MKT swine at 24h after I/R.
Right, inﬂammatory cell inﬁltration was estimated by CD45-positive cell
counts per unit area (10
2 cells/mm
2). Values are mean±SEM (CONT, n=5;
MKT, n=5; ﬁve ﬁelds of each specimen; *p<0.05 vs. CONT, ANOVA). (C)
Deposition of exogenous MK protein labeled with rhodamine in the peri-infarct
area. Images were taken from LV tissue sections in a swine 24h after I/R.
Fluorescence signals of rhodamine are recognized predominantly in the
peri-infarct area (center) but not in the normal area (left) and infarct area (right).
the present study, we could demonstrate the anti-apoptotic effect
of MK by TUNEL staining in a large mammalian species. The
beneﬁt of anti-apoptotic action of MK may lead to a reduction of
secondary necrosis,which activates inﬂammation.
SIDE EFFECTS, LIMITATIONS, AND FUTURE ASPECTS
In this study, MK treatment did not cause any undesirable effect
on the hemodynamic parameters throughout the whole period
of 45min ischemia followed by 24h reperfusion. ECG para-
meters associated with conduction and repolarization were also
unchanged. It suggests that MK has enough safety margin from
the cardiovascular point of view when we consider future clinical
use. To conﬁrm the localization of exogenously injected MK, we
used MK protein labeled with rhodamine. Intracoronary injected
MK-rhodamine was restricted to the peri-infarct area at 24h after
injection. The MK-rhodamine was not found in the normal area.
Themechanismisprobablythespeciﬁcexpressionof aMKrecep-
tor in the injured myocardium (Takenaka et al.,2009). This aspect
is pivotal, because it may pave the way to intravenous medication
in a clinical setting.
There was a certain animal to animal variation of hemody-
namic parameters at baseline (before I/R insult). Both sBP and
dBP in CONT swine at baseline tended to be higher than those
in MKT swine (Figure 5). MKT baseline values of %IVS thick-
ening in echocardiography had a considerable SEM (Figure 3B).
We, therefore, cannot rule out possible inﬂuence of inadequate
randomization on the beneﬁcial effects of MK against myocardial
injury. This may be a limitation of the present study. However,the
statistical signiﬁcance of our data is not at debate, because both
for the echocardiographic data and the hemodynamic data each
animal served as its own control from baseline (“PRE”) till 24h
after reperfusion.
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We evaluated a practical treatment approach, aiming at pre-
venting cardiac damage, during the acute phase of myocardial
infarction. The proposed strategy consists of acute MK admin-
istration targeted at the infarct area and this report is the ﬁrst
that shows cardioprotective effects in a large animal model of
myocardial infarction and reperfusion.
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